327 filings
Page 12 of 17
4
Glickman Marc H.
30 Jul 19
Hancock Jaffe Laboratories / Marc H. Glickman ownership change
5:44pm
8-K
NVNO
enVVeno Medical Corporation
26 Jul 19
Regulation FD Disclosure
4:15pm
424B4
NVNO
enVVeno Medical Corporation
13 Jun 19
Prospectus supplement with pricing info
5:25pm
EFFECT
NVNO
enVVeno Medical Corporation
12 Jun 19
Notice of effectiveness
12:15am
CORRESP
NVNO
enVVeno Medical Corporation
10 Jun 19
Correspondence with SEC
12:00am
S-1
NVNO
enVVeno Medical Corporation
IPO registration
7 Jun 19
5:29pm
8-K
NVNO
enVVeno Medical Corporation
7 Jun 19
Hancock Jaffe Reports Early Positive Results from First-In-Human VenoValve Study
8:45am
144
NVNO
enVVeno Medical Corporation
30 May 19
Notice of proposed sale of securities
12:00am
UPLOAD
NVNO
enVVeno Medical Corporation
28 May 19
Letter from SEC
12:00am
4
Biodyne Holding, S.A.
24 May 19
Change in insider ownership
5:30pm
8-K
NVNO
enVVeno Medical Corporation
24 May 19
Departure of Directors or Certain Officers
8:30am
UPLOAD
NVNO
enVVeno Medical Corporation
21 May 19
Letter from SEC
12:00am
DRS
NVNO
enVVeno Medical Corporation
15 May 19
Draft registration statement
12:00am
10-Q
2019 Q1
NVNO
enVVeno Medical Corporation
Quarterly report
9 May 19
5:29pm
424B3
NVNO
enVVeno Medical Corporation
7 May 19
Prospectus supplement
5:01pm
EFFECT
NVNO
enVVeno Medical Corporation
7 May 19
Notice of effectiveness
12:15am
D/A
NVNO
enVVeno Medical Corporation
3 May 19
$2.7M in equity, sold $2.7M, 105 investors
5:13pm
POS AM
NVNO
enVVeno Medical Corporation
1 May 19
Prospectus update (post-effective amendment)
12:00am
8-K
NVNO
enVVeno Medical Corporation
30 Apr 19
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
8:35am
EFFECT
NVNO
enVVeno Medical Corporation
30 Apr 19
Notice of effectiveness
12:15am